17th Feb 2021 16:22
Scancell Holdings PLC - Oxford, England-based immunotherapies for treatment of cancer and infectious disease - Non-Executive Director Martin Diggle sells 400,000 shares via Vulpes Life Sciences Fund at 23.70 pence, worth about GBP94,800, on Tuesday. Vulpes now has 117.8 million shares, a 14.5% stake.
Current stock price: 26.18p, up 9.1% on Wednesday
Year-to-date change: up 87%
By Tom Waite; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Scancell Holdings